Acquisition highlights of BUGWORKS Research and a snapshot of its key metrics.

Founded in 2014, BUGWORKS Research operates in Health Tech industry. Initially concentrating on drug discovery for bacterial infections, the company has evolved its offerings to include a broader pipeline of anti-infective therapies. BUGWORKS announced a successful advancement of its flagship antibiotic compound through Phase 1 clinical trials, marking a significant milestone in its journey to address global health challenges. The company is further expanding its R&D capabilities with strategic collaborations in new geographical markets. Competing with companies such as Pandorum Technologies and String Bio.

Anand Anandkumar

Bala Subramanian

Founded in 2014, BUGWORKS Research has raised 36.11 Mn+ in funding from a total number of 12 investors.

BUGWORKS Research – Total Funding, Funding Over Time, Funding By Rounds and More.

Funding highlights of BUGWORKS Research and a snapshot of its key metrics.

Biotechnology Industry Research Assistance Council(BIRAC)

Baxter Ventures

3one4 Capital

Lord Jim O'Neill

IM Holdings BV

Featherlite

Acquipharma

Lightrock

Global Brain Corporation

UTEC - The University of Tokyo Edge Capital Partners

Kiran Mazumdar-Shaw

Investment highlights of BUGWORKS Research and a snapshot of its key metrics.

Bugworks Research - A Health Tech Funded Company Based Out Of Bengaluru

BUGWORKS Research

A snapshot of highlights, scale, and metrics

An overview of key people in BUGWORKS Research.

A Health Tech Funded Company Based Out Of Bengaluru

BUGWORKS Research - Financials, Revenue, P&L Statement, Balance Sheet, Cash Flow & More